Skip to content
KemetiCare
Portrait of Dr. Jeffrey B. Hubbard

Founder

Dr. Jeffrey B. Hubbard, M.D., M.S.

Founder, President & Chief Executive Officer, KemetiCare Holdings, Inc.

Jeffrey B. Hubbard, M.D., M.S.—known publicly as Dr. Jeff—is a physician, biomedical researcher, entrepreneur, and educator. He founded KemetiCare in 2014 to advance culturally grounded, prevention-focused wellness and personalized support, and help reduce health disparities.

Background

Training informed by research and real life.

Education & training

  1. Postdoctoral Research Training and Fellowship, Anesthesiology, Critical Care & Pain Medicine
    Beth Israel Deaconess Medical Center / Harvard Medical School, Boston, MA — completed 2016
  2. Doctor of Medicine
    Southern Illinois University School of Medicine, Springfield, IL — 2013
  3. Medical/Dental Education Preparatory Program (MEDPREP)
    Southern Illinois University, Carbondale, IL — 2009
  4. Master of Science in Physiology, Molecular-Biology Concentration
    Florida A&M University — 2008
  5. Bachelor of Science in Biology
    Florida A&M University — 2006
Dr. Hubbard engaged in research and scientific review

Research background

Research Fellow in the Department of Anesthesiology, Critical Care and Pain Medicine at Beth Israel Deaconess Medical Center and Harvard Medical School (2013–2016), contributing to cardiovascular, perioperative, molecular and translational research — including STAT3 cell-survival signaling in diabetic myocardium after cardiopulmonary bypass, oxidative stress and gene expression in cardiac myocytes, postoperative atrial fibrillation, transfusion-associated complications, and acute kidney injury.

Areas of focus

  • Preventive health and chronic-disease risk reduction
  • Functional and integrative wellness strategy
  • Health equity and culturally responsive community programming
  • Digital health and AI-assisted wellness engagement
  • Biomedical research and scientific communication
  • Corporate, faith, school and community wellness-program design

Speaking topics

  • From sick care to prevention
  • Health disparities, trust, and culturally responsive engagement
  • Personalized wellness and the individual's blueprint for optimal health
  • AI-assisted engagement and the future of preventive health

Selected scholarship

Peer-reviewed publication

Cardiopulmonary Bypass Decreases Activation of the Signal Transducer and Activator of Transcription 3 (STAT3) Pathway in Diabetic Human Myocardium

Owais K, Huang T, Mahmood F, Hubbard J, Saraf R, Bardia A, Khabbaz KR, Li Y, Bhasin M, Sabe AA, Sellke F, Matyal R. The Annals of Thoracic Surgery. 2015;100(5):1636–1645.

PubMed DOI

Presentations & Professional Writing

  • Orhurhu V, Owais K, Hubbard JB, et al. “Preoperative aspirin use and postoperative outcomes in non-emergency cardiac surgery patients.” Poster, American Society of Anesthesiologists Annual Meeting, 2014.
  • Hubbard JB, Owais K, Orhurhu V, et al. “Oxidative stress leads to altered gene expression in cardiac myocytes following cardiopulmonary bypass in patients with poorly controlled type II diabetes versus non-diabetics.” Oral presentation, ASA Annual Meeting, 2014.
  • Hubbard JB, Jeganathan J, Owais K. “Impact of preoperative moderate/severe mitral regurgitation on two-year outcome after TAVR and SAVR: insight from the PARTNER Trial Cohort A.” Society of Cardiovascular Anesthesiologists Newsletter, 2014.
  • Hubbard JB, Owais K. “CON: Dexmedetomidine use in cardiac surgery.” Society of Cardiovascular Anesthesiologists Newsletter, 2014.
Dr. Hubbard presenting general wellness education

Ask Dr. Jeff M.D.

General wellness education, in plain language.

Ask Dr. Jeff M.D. provides general wellness education within the Wellness Kommunity, along with eBooks such as Photobiomodulation 101. It does not provide individual diagnosis or treatment and does not create a physician-patient relationship.

Start Your 30-Day Experience
About KemetiCare
Wellness SnapshotStart Your 30-Day Experience